In today’s digital landscape, organizations face the dual challenge of driving technological innovation while safeguarding ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Discover what CRM reports are, their benefits, key features, and how they help businesses analyze customer data, sales, and ...

With the right narrative, you can position your company as a visionary force worth investing in, turning your North Star into ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...

The B2B sales landscape is undergoing a rapid transformation. Economic uncertainty, shifting buyer expectations, and technologies like generative AI are compelling sales leaders to rethink how they ...

Researchers at the Kennedy Institute have developed a new computational framework that allows simultaneous analysis of gene expression and mechanical forces within cells and tissues, uncovering ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.